RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
World's Leading Provider of Cutting-Edge Smart Ring Solutions NEW YORK, May 10, 2026 /PRNewswire/ -- RingConn opened Gen 3 pre-orders on May 5th ahead of its official May 29th launch, marking the occasion with a feature on the iconic One Times Square billboard in New York City on the first day of pre-orders. The next-generation device combines holistic health...
Study pinpoints 45 years as the critical threshold for a significant downturn in male fertility
BEIJING, May 10, 2026 /PRNewswire/ -- Forty-five years has been identified as the critical age threshold at which elevated sperm DNA fragmentation significantly reduces fertility potential in men. High levels of DNA fragmentation, defined as a breakdown of genetic material inside sperm cells, make it harder for sperm to fertilise an egg...
Emotional burden of infertility can undermine lifestyle choices that may help women conceive
BEIJING, May 10, 2026 /PRNewswire/ -- The emotional burden of infertility actively undermines the capacity of many women to make sustained lifestyle changes, including weight loss and physical activity, that can improve their chances of becoming pregnant. A global conference on assisted reproduction in Beijing heard today that the gap between lifestyle...
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
NEWARK, Del., May 10, 2026 /PRNewswire/ -- ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrative process to a streamlined, purchase-based authorization model. This policy shift addresses the industry-wide challenge of compliance delays by embedding intellectual property clearance directly into the procurement process, thereby empowering global biopharmaceutical...
South and East Asia identified as hotspots of global warming related impacts on male fertility
BEIJING, May 9, 2026 /PRNewswire/ -- A major new study has shown that South and East Asia dominate patterns of global warming related decline in male fertility with the strongest and most consistent evidence coming from India, Pakistan and the southern parts of China. The effects of increased environmental temperatures on male...
Psychosocial support is vital to help those living with infertility to overcome treatment barriers, including stigmas, myths and taboos about IVF
BEIJING, May 9, 2026 /PRNewswire/ -- Diverse cultural or religious values across the Asia Pacific region mean that many people living with infertility face challenging family or societal attitudes when considering assisted reproductive treatment to achieve their dreams of parenthood. In many cases infertility generates personal shame and feelings of failure, as...
World’s First | Mabwell’s 9MW5211 Receives FDA Clearance for Clinical Trial Application
SHANGHAI, May 9, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug (IND) application for 9MW5211, its independently developed novel antibody, has received clearance from the U.S. Food and Drug Administration (FDA) to conduct clinical studies for the treatment of inflammatory bowel disease (IBD). Clinical trial applications...
AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
ROCKVILLE, Md., May 8, 2026 /PRNewswire/ -- USA -- AAVnerGene Inc. today announced the launch of AAVone®2.1, the next-generation evolution of its proprietary AAVone® single-plasmid AAV production system, designed to improve AAV vector productivity, full-capsid yield, manufacturing efficiency, and cost effectiveness. AAVone®2.1 has achieved ~1x1016 genome copies (GC)/L of cell culture...
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
CHENGDU, China, May 8, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that the sNDA (the "Application") for the Company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) was accepted for review by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA)...
What Sets Medtec China Apart from Other Medical Device Manufacturing Expos
SHANGHAI, May 8, 2026 /PRNewswire/ -- Building a successful medical device requires precise engineering, reliable materials, and a resilient supply chain. Finding the right partners to bring your vision to life is a major challenge. The Medtec China trade show solves this problem. As a leading medical device development expo, it stands as a premier gathering dedicated entirely to...
